Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers

Inclusion Criteria: * Healthy male who are ≥19, \<50 years old * Man who weights over 55kg and whose BMI is 18\~30(kg/m2) * Man who doesn't have any chronic disease or history of disease Exclusion Criteria: * man who has or had any clinically relevant disease of liver, kidney, nervous/respiratory/musculoskeletal/cardiovascular/hemato-oncology system or neuropsychiatry